ASX Share rice
Fri 14 Aug 2020 - 05:22:pm (Sydney)

BD1 Share Price

BARD1 LIFE SCIENCES LIMITEDBD1Health Care Equipment & Services

BD1 Company Information


BARD1 Life Sciences Limited




Diagnostics & Research

GIC Industry:

Health Care Providers & Services

GIC Sub Industry:

Health Care Services


Unit 202 39 Mends Street South Perth Australia 6151


61 8 9381 9550

Chief Exec. Officer:

Dr. Leearne Maree Hinch BSc., B.V.M.S., M.R.C.V.S., M.B.A.

Founder, Exec. Director & Chief Scientific Officer:

Dr. Irmgard Irminger-Finger B.Sc., M.Sc., PD, Ph.D.

Managing Director:

Mr. Peter Lynton Gunzburg B Comm, ASIA

CFO & Company Sec.:

Mr. Tony Di Pietro

Chief Operating Officer:

Mr. Carl S. Stubbings

Company Overview:

BARD1 Life Sciences Limited engages in the research and development of non-invasive diagnostic tests for early detection of cancer in Australia. It is developing BARD1 lung cancer test, a screening test for the early detection of lung cancer in high-risk asymptomatic individuals; and BARD1 ovarian cancer test to detect ovarian cancer in high-risk women with a family history of breast/ovarian cancer or carrying BRCA1/2 mutations. The company has a collaboration with the Institute for Respiratory Health to evaluate a potential BARD1 cancer vaccine for the prevention and/or treatment of cancer in animal models. BARD1 Life Sciences Limited is based in South Perth, Australia.

BD1 Share Price Information

Shares Issued:


Market Capitalisation:


Revenue (TTM):


Earnings per Share:


Operating Margin (TTM):


Return On Assets (TTM):


Return On Equity (TTM):


Quarterly Revenue Growth (YOY):


Gross Profit(TTM):


Diluted Earnings Per Share (TTM):


BD1 CashFlow Statement

CashFlow Date:


Change To Liabilities:


Net Income:


Total Cash From Operating Activities:


Change To Account Receivables:


Sale Purchase Of Stock:


Capital Expenditures:


BD1 Income Statement

Income Date:


Income Before Tax:


Net Income:


Gross Profit:


Operating Income:


Total Revenue:


Total Operating Expenses:


Cost Of Revenue:


BD1 Balance Sheet

Balance Sheet Date:


Total Liabilities:


Total Stockholder Equity:


Other Current Liabilities:


Total Assets:


Common Stock:


Retained Earnings:


Other Liabilities:




Total Current Liabilities:


Net Tangible Assets:


Total Current Assets:


Net Receivables:


Short-Term Investments:


Accounts Payable:


Non Currrent Assets (Other):


Short-Term Investments:


Non Current Liabilities Total:


BD1 Share Price History

BD1 News

16 May, 2020
We often see insiders buying up shares in companies that perform well over the long term. The flip side of that is...
17 Mar, 2020
The last three months have been tough on BARD1 Life Sciences Limited (ASX:BD1) shareholders, who have seen the share...
17 Jan, 2020
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although
18 Nov, 2019
Every investor in BARD1 Life Sciences Limited (ASX:BD1) should be aware of the most powerful shareholder groups...